Sectors
PDSB
PDS Biotechnology Corporation
0.81
2 x 0.62
2 x 0.98
bid
ask
-
0.04
4.36%
2 @ 05:05 AM
0.85 +0.04 (5.25%)
| Ytd | 4.61% | |
| 1y | -23.29% |
0.75
day range
0.90
0.20
52 week range
1.55
| Open | 0.83 | Prev Close | 0.84 | Low | 0.75 | High | 0.90 | Mkt Cap | 58.38M |
| Vol | 18.98M | Avg Vol | 20.74M | EPS | -0.64 | P/E | N/A | Forward P/E | -1.18 |
| Beta | 1.93 | Short Ratio | 10.47 | Inst. Own | 12.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.50 | 200-d Avg | 0.80 | 1yr Est | 11.50 |
| Income Statement | |||
| Operating Expenses | 6.50M | ||
| Research and Development Expense | 3.27M | ||
| Selling, General and Administrative Expense | 3.23M | ||
| Operating Income | -6.50M | ||
| Interest Expense | 3.25M | ||
| Net Income | -9.75M | ||
| Net Income Common Stock | -9.75M | ||
| Net Income Common Stock (USD) | -9.75M | ||
| Consolidated Income | -9.75M | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -6.50M | ||
| Earning Before Interest & Taxes (USD) | -6.50M | ||
| Weighted Average Shares | 55.66M | ||
| Weighted Average Shares Diluted | 55.66M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.60M | ||
| Cash and Equivalents (USD) | 5.60M | ||
| Current Assets | 7.05M | ||
| Property, Plant & Equipment Net | 213.44K | ||
| Total Assets | 8.81M | ||
| Debt Current | 4.35M | ||
| Total Debt | 4.36M | ||
| Current Liabilities | 12.38M | ||
| Debt Non-Current | 9.48K | ||
| Total Liabilities | 12.39M | ||
| Accumulated Retained Earnings (Deficit) | -233.71M | ||
| Shareholders Equity | -3.58M | ||
| Shareholders Equity (USD) | -3.58M | ||
| Assets Non-Current | 1.76M | ||
| Total Debt (USD) | 4.36M | ||
| Liabilities Non-Current | 9.48K | ||
| Trade and Non-Trade Payables | 6.39M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 15.13K | ||
| Net Cash Flow from Financing | -13.27M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.06M | ||
| Issuance (Purchase) of Equity Shares | 1.15M | ||
| Issuance (Repayment) of Debt Securities | -14.42M | ||
| Net Cash Flow from Operations | -2.79M | ||
| Share Based Compensation | 1.13M | ||